作者:国际循环网 发布于:2010-04-02
以前,第一个比较BMS和SES在CTO病变的价值的PRISON II研究3个月随访发现 SES支架可显著降低患者节段内再狭窄和支架内再狭窄的发生率,并伴有MACE事件的降低和随后的血管重...
Professor Run-Lin Gao introduced the opening ceremony this evening in the Main Hall of the CNCC, proudly welcoming the packed hall and acknowledging the roles ...
There is enough evidence to say that HDL acts as a protective agent against coronary heart disease, was the opening message from Professor Ron Waksman from the...
Introduced as a provocative topic, Professor Maurice Buchbinder, Foundation for Cardiovascular Medicine, La Jolla, California admitted himself to finding th...
As an overview of contemporary therapy for coronary artery disease, a contingent of invited speakers presented brief lectures and discussion on the topic in th...
与旧款耐用型HeartMate XVE(一种脉冲血流左心室辅助装置)相比,新型HeartMate II左心室辅助装置(LVAD;一种连续血流左心室辅助装置)的效果如何?
共筛检766例患者,研究人员将180例患者随机分入接受常规通气支持组(n = 90)或ECMO组(n = 90)。入选标准为年龄18~65岁之间、具有严重但可能逆转的呼吸衰竭患者。排除标...
作者:国际循环网 发布于:2010-04-01
肾动脉狭窄的基本病因影响介入(肾动脉支架术)治疗效果:此研究入选患者绝大多数系动脉粥样硬化所致的肾动脉狭窄,相当部分是在原发性高血压的基础上发生了肾动脉硬化,即...
专家视角丨高血压管理新篇:余静教授202..
心房颤动患者和动脉粥样硬化患者磁共振..
ESC专访|郭豫涛教授解析mAFA扩展试验结..
波兰国家注册数据:药物涂层球囊治疗冠..